Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.37 |
| ▸ | RORC | P51449 | 9/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24034887 | 1.00 | ENPP3 (0.40) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034888 | 1.00 | ENPP3 (0.40) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034878 | 0.98 | ENPP3 (0.38) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034923 | 0.95 | ENPP3 (0.42) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034921 | 0.95 | ENPP3 (0.42) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034881 | 0.92 | AR (0.39) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL38652911 | 0.91 | ENPP3 (0.43) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL21717825 | 0.91 | ENPP3 (0.43) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034944 | 0.87 | KDM4E (0.41) | ENPP3PTGER4RORCCA1CA2 | |
| SCHEMBL24034946 | 0.87 | KDM4E (0.41) | ENPP3PTGER4RORCCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355092-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355092-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OXA1L | ENPP3 1422/4885PTGER4 1792/4885RORC 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.